stars 1 stars 2 stars 3

Cornerstone Pharmaceuticals, Inc. is committed to changing the way cancer is treated through the discovery and development of innovative drug therapies that target distinctive metabolic processes of cancer cells. Our research into cancer metabolism has led to the discovery of novel, first-in-class drugs and drug delivery technologies that have the potential to revolutionize cancer treatment. - CPI-613, our lead drug from our Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. CPI-613 is currently in Phase I/II clinical trials. - Emulsiphan, our novel drug delivery technology, is designed to dramatically improve the safety and usefulness of existing and novel cancer therapies. Our platforms are market driven and combine novel drug and formulation strategies that target metabolic features of cancer cells that are characteristic of diverse tumor types and are designed to provide the safest and most effective treatments for multiple types of cancer.

View Top Employees from Cornerstone Pharmaceuticals
Website http://www.cornerstonepharma.com/
Revenue $11.8 million
Funding $13.3 million
Employees 11 (9 on RocketReach)
Founded 2000
Address 1 Duncan Dr, Cranbury, New Jersey 08512, US
Phone (609) 409-7050
Fax (609) 409-6035
Industry Biotechnology, Pharmaceuticals, Cancer Metabolism, Healthcare, Science and Engineering, Medical, Drug Manufacturing & Research, Health Care, Pharmaceutical
Competitors Alios BioPharma, Forma Therapeutics, MBC Pharma, Inc., Sagimet Biosciences
SIC SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies
NAICS NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies

Cornerstone Pharmaceuticals Questions

The Cornerstone Pharmaceuticals annual revenue was $11.8 million in 2023.

Robert Rodriguez is the President and Chief Operations Officer of Cornerstone Pharmaceuticals.

9 people are employed at Cornerstone Pharmaceuticals.

Cornerstone Pharmaceuticals is based in Cranbury, New Jersey.

The NAICS codes for Cornerstone Pharmaceuticals are [32, 325, 3254, 32541].

The SIC codes for Cornerstone Pharmaceuticals are [28, 283, 2834].

Top Cornerstone Pharmaceuticals Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users